| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $0 ) |
| 2024 | 2022 | ECLIPSE BIOINNOVATIONS, INC | 5770 OBERLIN DR | SAN DIEGO | CA | 92121-1723 | SAN DIEGO | USA | R44HG010603 | Development of chimeric read amplification into a robust method for profiling targets of specific microRNAs and global amplification of all microRNA:mRNA pairings transcriptome-wide | 000 | 3 | NIH | 2/6/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| 2023 | 2021 | ECLIPSE BIOINNOVATIONS, INC. | 5770 OBERLIN DR | SAN DIEGO | CA | 92121-1723 | SAN DIEGO | USA | R44HG010603 | Development of chimeric read amplification into a robust method for profiling targets of specific microRNAs and global amplification of all microRNA:mRNA pairings transcriptome-wide | 000 | 2 | NIH | 11/18/2022 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $861,551 ) |
| 2022 | 2022 | ECLIPSE BIOINNOVATIONS, INC. | 5770 OBERLIN DR | SAN DIEGO | CA | 92121-1723 | SAN DIEGO | USA | R44HG010603 | Development of chimeric read amplification into a robust method for profiling targets of specific microRNAs and global amplification of all microRNA:mRNA pairings transcriptome-wide | 001 | 3 | NIH | 9/20/2022 | $0 |
| 2022 | 2022 | ECLIPSE BIOINNOVATIONS, INC. | 5770 OBERLIN DR | SAN DIEGO | CA | 92121-1723 | SAN DIEGO | USA | R44HG010603 | Development of chimeric read amplification into a robust method for profiling targets of specific microRNAs and global amplification of all microRNA:mRNA pairings transcriptome-wide | 000 | 3 | NIH | 9/9/2022 | $861,551 |
|
| Issue Date FY: 2021 ( Subtotal = $1,137,682 ) |
| 2021 | 2021 | ECLIPSE BIOINNOVATIONS, INC. | 6195 CORNERSTONE CT E STE 105 | SAN DIEGO | CA | 92121-4728 | SAN DIEGO | USA | R44HG010603 | Development of chimeric read amplification into a robust method for profiling targets of specific microRNAs and global amplification of all microRNA:mRNA pairings transcriptome-wide | 000 | 2 | NIH | 9/22/2021 | $1,137,682 |
| 2021 | 2019 | ECLIPSE BIOINNOVATIONS, INC. | 5770 OBERLIN DR | SAN DIEGO | CA | 92121-1723 | SAN DIEGO | USA | R43HG010603 | Unambiguous transcriptome-wide identification of microRNA:mRNA interactions through enhanced chimeric read amplification | 000 | 1 | NIH | 2/5/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $0 ) |
| 2020 | 2018 | ECLIPSE BIOINNOVATIONS, INC. | 6195 CORNERSTONE CT E STE 105 | SAN DIEGO | CA | 92121-4728 | SAN DIEGO | USA | R44HG009875 | A robust kit, standards, and software for identifying RNA binding protein targets | 000 | 2 | NIH | 2/3/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $349,750 ) |
| 2019 | 2019 | ECLIPSE BIOINNOVATIONS, INC. | 6185 CORNERSTONE COURT E SUITE 106 | SAN DIEGO | CA | 92121-4726 | SAN DIEGO | USA | R43HG010603 | Unambiguous transcriptome-wide identification of microRNA:mRNA interactions through enhanced chimeric read amplification | 000 | 1 | NIH | 9/17/2019 | $349,750 |
|
| Issue Date FY: 2018 ( Subtotal = $305,093 ) |
| 2018 | 2018 | ECLIPSE BIOINNOVATIONS, INC. | 6185 CORNERSTONE COURT E SUITE 106 | SAN DIEGO | CA | 92121-4726 | SAN DIEGO | USA | R44HG009875 | A robust kit, standards, and software for identifying RNA binding protein targets | 000 | 2 | NIH | 8/15/2018 | $305,093 |
|
| Issue Date FY: 2017 ( Subtotal = $1,278,018 ) |
| 2017 | 2017 | ECLIPSE BIOINNOVATIONS INC | 10210 CAMPUS POINT DR STE 150 | SAN DIEGO | CA | 92121-1522 | SAN DIEGO | USA | R44HG009875 | A robust kit, standards, and software for identifying RNA binding protein targets | 001 | 1 | NIH | 9/26/2017 | $684 |
| 2017 | 2017 | ECLIPSE BIOINNOVATIONS INC | 10210 CAMPUS POINT DR STE 150 | SAN DIEGO | CA | 92121-1522 | SAN DIEGO | USA | R44HG009875 | A robust kit, standards, and software for identifying RNA binding protein targets | 000 | 1 | NIH | 9/20/2017 | $1,277,334 |
|
|